SPECT/CT 的最新进展
本文综述了 SPECT/CT 在核医学成像中的重要进展,包括高质量衰减校正与代谢和解剖图像融合,以及 CZT 探测器、绝对单位定量、多床位全身 SPECT 采集和新型非平行孔准直器等已进入临床的新技术;多针孔准直器、蒙特卡罗迭代重建、列表模式采集和 α 发射体定量成像等仍待临床常规实施;未来深度学习有望应用,并需推动定量 SPECT 标准化以实现跨机构可比性。
要点
- SPECT/CT 通过衰减校正和代谢与解剖图像融合,显著推进了核医学成像。
- CZT 探测器、绝对单位定量、多床位全身 SPECT 和非平行孔准直器已进入临床应用。
- 多针孔准直器、蒙特卡罗迭代重建、列表模式采集和 α 发射体定量成像仍待临床常规实施。
核心结论
- SPECT/CT 的出现标志着核医学成像的重要进步,可实现高质量衰减校正及代谢与解剖图像融合。
- 深度学习有望应用于核医学成像,印证研究团队报告的有前景结果。
- 需更多努力推动定量 SPECT 标准化,以实现放射性药物摄取及剂量学结果等衍生量的跨机构可比性。
- 多种可被 SPECT 成像的治疗性放射性药物的上市授权将推动对 SPECT/CT 的兴趣,并确保其继续作为核医学的主力设备。
研究设计与样本
- 本文为综述,总结 SPECT/CT 近期技术进展及文献报道的新方法。
主要发现
- 半导体碲锌镉(CZT)探测器、以绝对单位定量放射性药物摄取、多床位全身 SPECT 采集和新型非平行孔准直器等新技术已进入临床应用。
- 多针孔准直器、采用蒙特卡罗投影器的迭代重建、列表模式 SPECT 采集和 α 发射体定量成像等新方法已有文献报道,但仍待临床常规实施。
局限性
- 多种新方法虽有文献报道,但仍待临床常规实施。
- 需更多努力推动定量 SPECT 标准化,以实现跨机构可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The debut of multimodal Single Photon Emission Computed Tomography/X-ray Computed Tomography (SPECT/CT) has signified an important advancement of Nuclear Medicine imaging by allowing for high-quality attenuation correction and co-registration/fusion of metabolic and anatomical images. This progress in SPECT instrumentation continued and resulted in the clinical application of several new techniques, such as for example, semiconductive Cadmium-Zinc-Telluride (CZT) detectors, quantification of radiopharmaceutical uptake in absolute units, whole-body SPECT acquisitions with multiple bed positions, and novel non-parallel hole collimators. Many other new methods were reported from literature during the last years, but still await implementation in clinical routine. Here, examples are multipinhole collimators, iterative reconstruction with Monte-Carlo projectors, list-mode SPECT acquisitions, and quantitative imaging of alpha-emitters. For the future, it could be expected that deep-learning approaches would be applied for Nuclear Medicine imaging, confirming the promising results reported by research groups. More efforts should be made for standardizing quantitative SPECT, to allow for inter-site comparability of radiopharmaceutical uptake and derived quantities such as dosimetry results. The awaited market authorization of several SPECT-imageable therapeutic radiopharmaceuticals will drive the interest in SPECT/CT and ensure that it remains the workhorse of Nuclear Medicine.
引用
- Ritt P. Recent Developments in SPECT/CT. Semin Nucl Med. 2022. PMID: 35210065. doi:10.1053/j.semnuclmed.2022.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。